Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells
Nature Medicine2017Vol. 23(10), pp. 1234–1240
Citations Over TimeTop 1% of 2017 papers
Elodie M. Kuntz, Pablo Baquero, Alison M. Michie, Karen Dunn, Saverio Tardito, Tessa L. Holyoake, G. Vignir Helgason, Eyal Gottlieb
Related Papers
- → CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia(2016)42 cited
- → Quantitative approaches to analyzing imatinib-treated chronic myeloid leukemia(2007)27 cited
- → Efficacy of imatinib mesylate (STI571) in chronic neutrophilic leukemia with t(15;19): Case report(2004)15 cited
- → Simultaneously occurring chronic myelogenous leukemia and gastrointestinal stromal tumors treated with imatinib(2006)
- Molecular Monitoring of Chronic Myeloid Leukemia Treated with Imatinib Mesylate(2007)